Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in North America, Europe, and the Asia Pacific. It operates in two segments, Medical, and Nuclear & Safety. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as product handling, medical imaging furniture, and rehabilitation products. This segment improves the quality and safety of cancer care delivery; and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company also offers include radiation measurement and monitoring solutions, reactor instrumentation and control detectors, imaging systems and cameras, and waste management systems; laboratory and scientific analysis systems comprising gamma/alpha spectroscopy, alpha/beta counting, specialty detectors, and spectroscopy software; radiation measurement and health physics instrumentation; and contamination and clearance monitors. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. Mirion Technologies, Inc. was incorporated in 2005 and is headquartered in Atlanta, Georgia.
Ticker
MIR
Exchange
NYSE
Sector
Industrials
Industry
Specialty Industrial Machinery
Market cap
$4.41B
52-week range
$14.04 - $28.71
Valuation
Share price
$17.97 (close of Nov 6, 2026)
P/E (TTM)
138.23x
Price to book
2.40x
Price to free cash flow
26.26x
Enterprise value
$5.25B
Book value per share
$7.48
Price performance
Period
Change
1 day
+4.90%
5 days
-2.18%
1 month
+10.45%
3 months
+19.64%
6 months
-11.87%
Year to date
-23.27%
1 year
-34.77%
3 years
+116.77%
5 years
+59.59%
All time
+80.60%
Short interest
As of
Oct 15, 2026
Short % of float
24.94%
Shares short
41.19M
Days to cover
8.66
Change since prior report
+7.31%
Source
FINRA consolidated short interest
Profitability and growth
Return on equity
1.50%
Return on invested capital
1.54%
Return on assets
0.80%
Return on capital employed
1.57%
Gross margin
47.40%
Net margin
3.11%
EBITDA margin
20.49%
Revenue growth
7.50%
Free cash flow growth
112.52%
Cash flow and balance sheet
Free cash flow yield (TTM)
3.81%
Current ratio
3.02x
Net debt to EBITDA
3.66x
Latest reported year
Period end
Dec 31, 2025
Fiscal year
2025
Revenue
$925.40M
Cost of revenue
$486.80M
Gross profit
$438.60M
EBITDA
$189.60M
Net income
$28.80M
Earnings per share
$0.13
Research and development
$38.90M
Interest expense
$42.20M
Shares outstanding
229.96M
Income statement by year
Period end
Revenue
Gross profit
Net income
EPS
2025-12-31
$925.40M
$438.60M
$28.80M
$0.13
2024-12-31
$860.80M
$399.70M
-$36.10M
-$0.18
2023-12-31
$800.90M
$356.40M
-$96.90M
-$0.49
2022-12-31
$717.80M
$310.10M
-$276.90M
-$1.53
2021-12-31
-
-
-$158.40M
$0.00
2021-06-30
$611.60M
$251.80M
-$158.30M
-$24.18
2020-12-31
-
-
-$45.26M
$0.00
2020-06-30
$478.20M
$197.00M
-$119.10M
-$18.45
2019-12-31
-
-
-$341
$0.00
2019-06-30
$440.10M
$188.20M
-$122.00M
-$19.36
Margins and returns by year
Period end
Gross margin
Net margin
Return on equity
Return on capital
2025-12-31
47.40%
3.11%
1.50%
1.54%
2024-12-31
46.43%
-4.19%
-2.32%
0.97%
2023-12-31
44.50%
-12.10%
-6.25%
-0.67%
2022-12-31
43.20%
-38.58%
-18.87%
-12.07%
2021-12-31
-
-
-8.88%
-5.99%*
2021-06-30
41.17%
-25.88%
-
21.29%
2020-06-30
41.20%
-24.91%
-
-
2019-12-31
-
-
-7.81%
-7.81%*
2019-06-30
42.76%
-27.72%
-
-
* Estimated EBIT: pre-tax income + net interest. This company reports no operating income line.